NCT06958536: A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease
- State
- Under way
- Phase
- Phase 2
- People
- 99 planned
- Started
- 3 Jun 2025
- Primary completion
- 17 Dec 2026
- Arms
- Brivekimig Dose Regimen A, Brivekimig Dose Regimen B
- Results
- None posted
- 6 May 2025: Trial registered
- 3 Jun 2025: Trial started